Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsTRANSDERMALStandard

BUPRENORPHINE

BUPRENORPHINE

Standard Dose
15MCG/HR
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription

Key Takeaways

  • Primary indication: Marketing status: Prescription
  • Approval overview BUPRENORPHINE is listed in Drugs@FDA under application 211586 (ANDA).
  • Marketing status: Prescription Active ingredient BUPRENORPHINE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 15MCG/HR Sponsor AMNEAL Submission history Latest submission status date: 2024-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUPRENORPHINE is listed in Drugs@FDA under application 211586 (ANDA). Marketing status: Prescription Active ingredient BUPRENORPHINE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 15MCG/HR Sponsor AMNEAL Submission history Latest submission status date: 2024-10-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.